Morning Buzz: Prana Biotechnology (PRAN), Heron Therapeutics (HRTX), Vascular Biogenics (VBLT), Clovis Oncology (CLVS)
June 01, 2015 at 09:41 AM EDT
Prana Biotechnology Limited (PRAN) shares surged 19.26% to $1.61 in early trading following the company’s announcement that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s disease, stating that Prana has shown that PBT2 might be of significant benefit for patients with Huntington’s disease. Shares of Heron Therapeutics, Inc. (HRTX) […] View the full post at: Morning Buzz: Prana Biotechnology (PRAN), Heron Therapeutics (HRTX), Vascular Biogenics (VBLT), Clovis Oncology (CLVS) Related posts: Morgan Stanley’s Debt-Equity Clock Says it’s Time to Own Stocks WHO Raises Swine Flu Pandemic Level to Phase 5 Papandreou Says Greek ‘Survival’ at Stake in Talks
